{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T07:04:37Z","timestamp":1784185477048,"version":"3.55.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"EuroQol Research Foundation, The Netherlands","award":["92-RA"],"award-info":[{"award-number":["92-RA"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Qual Life Outcomes"],"DOI":"10.1186\/s12955-026-02548-2","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T16:04:15Z","timestamp":1779379455000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["An exploratory analysis of interaction effects in EQ-5D valuation using saturated EQ VAS datasets from the Netherlands, the United Kingdom, and China"],"prefix":"10.1186","volume":"24","author":[{"given":"Zhihao","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan M.","family":"Ramos-Go\u00f1i","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Kind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Busschbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"issue":"10","key":"2548_CR1","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s40273-016-0404-1","volume":"34","author":"M Oppe","year":"2016","unstructured":"Oppe M, Rand-Hendriksen K, Shah K, Ramos-Goni JM, Luo N. EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes. PharmacoEconomics. 2016;34(10):993\u20131004.","journal-title":"PharmacoEconomics"},{"issue":"4","key":"2548_CR2","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.jval.2014.04.002","volume":"17","author":"M Oppe","year":"2014","unstructured":"Oppe M, Devlin NJ, van Hout B, Krabbe PF, de Charro F. A program of methodological research to arrive at the new international EQ-5D-5L valuation protocol. Value Health. 2014;17(4):445\u201353.","journal-title":"Value Health"},{"issue":"1","key":"2548_CR3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jval.2018.05.010","volume":"22","author":"E Stolk","year":"2019","unstructured":"Stolk E, Ludwig K, Rand K, van Hout B, Ramos-Goni JM. Overview, Update, and Lessons Learned From the International EQ-5D-5L Valuation Work: Version 2 of the EQ-5D-5L Valuation Protocol. Value Health. 2019;22(1):23\u201330.","journal-title":"Value Health"},{"key":"2548_CR4","unstructured":"Oppe M, Hout B. The \u2018power\u2019 of eliciting EQ-5D-5L values: the experimental design of the EQ-VT. EuroQol Working Paper Series [Internet]. 2017; (17003). Available from: https:\/\/euroqol.org\/wp-content\/uploads\/2016\/10\/EuroQol-Working-Paper-Series-Manuscript-17003-Mark-Oppe.pdf"},{"issue":"4","key":"2548_CR5","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.jval.2017.09.001","volume":"21","author":"Z Yang","year":"2018","unstructured":"Yang Z, Luo N, Bonsel G, Busschbach J, Stolk E. Selecting Health States for EQ-5D-3L Valuation Studies: Statistical Considerations Matter. Value Health. 2018;21(4):456\u201361.","journal-title":"Value Health"},{"issue":"1","key":"2548_CR6","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jval.2018.06.015","volume":"22","author":"Z Yang","year":"2019","unstructured":"Yang Z, Luo N, Bonsel G, Busschbach J, Stolk E. Effect of Health State Sampling Methods on Model Predictions of EQ-5D-5L Values: Small Designs Can Suffice. Value Health. 2019;22(1):38\u201344.","journal-title":"Value Health"},{"issue":"12","key":"2548_CR7","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/j.jval.2018.06.001","volume":"21","author":"A Nicolet","year":"2018","unstructured":"Nicolet A, Groothuis-Oudshoorn CGM, Krabbe PFM. Does Inclusion of Interactions Result in Higher Precision of Estimated Health State Values? Value Health. 2018;21(12):1437\u201344.","journal-title":"Value Health"},{"issue":"4","key":"2548_CR8","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.jval.2022.10.008","volume":"26","author":"MF Jonker","year":"2023","unstructured":"Jonker MF, Donkers B. Interaction Effects in Health State Valuation Studies: An Optimal Scaling Approach. Value Health. 2023;26(4):554\u201366.","journal-title":"Value Health"},{"issue":"12","key":"2548_CR9","doi-asserted-by":"publisher","first-page":"S397","DOI":"10.1016\/j.jval.2023.09.2082","volume":"26","author":"A Vasan Thakumar","year":"2023","unstructured":"Vasan Thakumar A, Luo N. MSR23 EQ-5D-5L Valuation Studies: Do the Effects of Dimensional Health Problems Interact with Each Other? Value Health. 2023;26(12):S397.","journal-title":"Value Health"},{"issue":"7","key":"2548_CR10","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.jval.2018.12.008","volume":"22","author":"Z Yang","year":"2019","unstructured":"Yang Z, Feng Z, Busschbach J, Stolk E, Luo N. How Prevalent Are Implausible EQ-5D-5L Health States and How Do They Affect Valuation? A Study Combining Quantitative and Qualitative Evidence. Value Health. 2019;22(7):829\u201336.","journal-title":"Value Health"},{"issue":"11","key":"2548_CR11","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/j.jval.2019.06.008","volume":"22","author":"Z Yang","year":"2019","unstructured":"Yang Z, Luo N, Oppe M, Bonsel G, Busschbach J, Stolk E. Toward a Smaller Design for EQ-5D-5L Valuation Studies. Value Health. 2019;22(11):1295\u2013302.","journal-title":"Value Health"},{"issue":"5","key":"2548_CR12","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.jval.2019.10.017","volume":"23","author":"M Hernandez Alava","year":"2020","unstructured":"Hernandez Alava M, Pudney S, Wailoo A. The EQ-5D-5L Value Set for England: Findings of a Quality Assurance Program. Value Health. 2020;23(5):642\u20138.","journal-title":"Value Health"},{"issue":"12","key":"2548_CR13","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1007\/s40273-025-01519-7","volume":"43","author":"N Luo","year":"2025","unstructured":"Luo N, Vasan Thakumar A, Cheng LJ, Yang Z, Rand K, Cheung YB, et al. Developing an EQ-5D-5L Value Set for Singapore. PharmacoEconomics. 2025;43(12):1419\u201331.","journal-title":"PharmacoEconomics"},{"issue":"7","key":"2548_CR14","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1097\/MLR.0000000000000283","volume":"55","author":"JM Ramos-Goni","year":"2017","unstructured":"Ramos-Goni JM, Pinto-Prades JL, Oppe M, Cabases JM, Serrano-Aguilar P, Rivero-Arias O. Valuation and Modeling of EQ-5D-5L Health States Using a Hybrid Approach. Med Care. 2017;55(7):e51\u20138.","journal-title":"Med Care"},{"issue":"11","key":"2548_CR15","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1097\/00005650-199711000-00002","volume":"35","author":"P Dolan","year":"1997","unstructured":"Dolan P. Modeling valuations for EuroQol health states. Med Care. 1997;35(11):1095\u2013108.","journal-title":"Med Care"},{"issue":"3","key":"2548_CR16","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/00005650-200503000-00003","volume":"43","author":"JW Shaw","year":"2005","unstructured":"Shaw JW, Johnson JA, Coons SJ. US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med Care. 2005;43(3):203\u201320.","journal-title":"Med Care"},{"issue":"1","key":"2548_CR17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/0272989X0102100102","volume":"21","author":"X Badia","year":"2001","unstructured":"Badia X, Roset M, Herdman M, Kind P. A comparison of United Kingdom and Spanish general population time trade-off values for EQ-5D health states. Med Decis Mak. 2001;21(1):7\u201316.","journal-title":"Med Decis Mak"},{"issue":"4","key":"2548_CR18","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/hec.673","volume":"11","author":"A Tsuchiya","year":"2002","unstructured":"Tsuchiya A, Ikeda S, Ikegami N, Nishimura S, Sakai I, Fukuda T, et al. Estimating an EQ-5D population value set: the case of Japan. Health Econ. 2002;11(4):341\u201353.","journal-title":"Health Econ"},{"key":"2548_CR19","doi-asserted-by":"crossref","unstructured":"Devlin NPD, Janssen B. Chapter 3, Analysis of EQ VAS Data. In: (CH). C, editor. Methods for Analysing and Reporting EQ-5D Data: Springer; 2020.","DOI":"10.1007\/978-3-030-47622-9"}],"container-title":["Health and Quality of Life Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12955-026-02548-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12955-026-02548-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12955-026-02548-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T06:19:48Z","timestamp":1784182788000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12955-026-02548-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2548"],"URL":"https:\/\/doi.org\/10.1186\/s12955-026-02548-2","relation":{},"ISSN":["1477-7525"],"issn-type":[{"value":"1477-7525","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"assertion":[{"value":"12 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Yang reports grants from The EuroQol Research Foundation, during the conduct of the study; grants from The EuroQol Research Foundation, outside the submitted work. Dr. Ramos-Go\u00f1i reports grants from The EuroQol Research Foundation, during the conduct of the study; grants from The EuroQol Research Foundation, outside the submitted work. Dr. Kind reports grants from The EuroQol Research Foundation, during the conduct of the study; grants from The EuroQol Research Foundation, outside the submitted work. Dr. Busschbach reports grants from The EuroQol Research Foundation, during the conduct of the study; grants from The EuroQol Research Foundation, outside the submitted work. All authors are members of the EuroQol Group.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"95"}}